King Pharmaceuticals KG General Liability — Year 2
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's general liability — year 2.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's general liability — year 2?
- King Pharmaceuticals (KG) reported general liability — year 2 of 10.4% in Q4 2025.
- What does general liability — year 2 mean?
- This metric represents the second year of development for general liability claims, allowing for the assessment of claim maturation and reserve adequacy. It helps stakeholders understand how initial loss estimates for a specific cohort evolve as more claims are reported and settled.